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system for formation of metal nanoparticles. Biosynthe-
sized AgNPs can be used as an antibacterial agent, which 
can be safe for eukaryotic cells.
Keywords Biogenic silver nanoparticles · Cytotoxicity · 
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Introduction
Nanotechnology deals with the development and utilization 
of structures and devices with organizational features at the 
intermediate scale between individual molecules and about 
100 nm. Attention is pointed for synthesis of nanoparticles 
(NPs) from noble metals like gold, silver, zinc or platinum 
with further applications in science and life [1]. Synthesis 
of nanoparticles by biological systems is becoming popu-
lar. Biosynthesized nanoparticles are less toxic to chemi-
cal equivalent and highly stable because of presence of 
proteins and cost-effective [2]. This leads many research-
ers to discover new methods for synthesis of nanoparticles 
by using organisms such as bacteria, fungi or plants. Silver 
nanoparticles (AgNPs) have gained attention due to anti-
bacterial activity including multidrug resistance (MDR) 
microorganisms [1, 3] and Mycobacterium tuberculosis 
[4]. Biogenic silver nanoparticles have also shown activ-
ity against viruses such as human immunodeficiency virus 
type 1 (HIV-1) or Herpex sp. [5] or antileukemia [6] and 
anticancer [7] properties.
However, together with broad applications, there is 
increasing concern related to the biological impacts of 
use of silver nanoparticles on a large scale and the pos-
sible risks to the environment and health. Nanometer size 
of nanoparticles allows them to easily enter to cells of liv-
ing organisms, leading to various cell injuries [8, 9]. The 
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potential cytotoxicity and genotoxicity of nanoparticles 
have risen significantly and have been studied intensively 
[10, 11]. One of the mechanisms responsible for induction 
of cytotoxic effect of AgNPs is reactive oxygen species 
(ROS) formation [12]. ROS may cause harmful effects both 
to human and to animals as well as in the environment. In 
this regard, there is increasing interest in the analysis of 
potential nanoparticle cytotoxicity. Moreover, since nano-
particles may affect not only the cells that compose cellu-
lar barriers (fibroblasts, endothelial or intestinal cells) but 
also the cells of the immune system; it is crucial to define 
the immunocompatibility of nanoparticles, especially those 
with potential medical application. The cells especially 
affected by the foreign particles such as bacteria, viruses 
and any other external stimuli are the immune cells of the 
innate immunity such as natural killer cells (NKs), dendritic 
cells (DC) and monocytes [13]. The latter are very sensi-
tive immune indicators of cell activation, and they sense 
antigens by Toll-like receptors (TLRs). When recognized, 
an antigen induced a cascade of signal transmission, which 
ends with the nuclear factor kappa-light-chain-enhancer of 
activated B cells (NF-κB) transcription factor activation, 
resulting in cytokine production such as interferon (IFN)-γ 
or interleukin (IL)-12 [14]. Those soluble molecules alarm 
other immune cells and initiate the inflammation process, 
which leads to a numerous harmful consequences.
The main aim of present work was the synthesis of silver 
nanoparticles from Streptomyces kasugaensis strain NH28 
with special reference to antibacterial activity as well as 
cytotoxic activity and immunosafety on in vitro models.
Materials and methods
Isolation of actinobacteria from acidic soil
The actinobacterial strain NH28 was isolated from humic 
layer of pine forest soil near Torun, Poland (52°55′37″N, 
18°42′11″E) on starch casein agar [15] at pH 4.5 using 
serial dilution method detailed by Golinska [16]. The aver-
age pH value of soil was estimated at 3.65 (±1.2). The 
strain was maintained on starch casein agar slopes at 4 °C.
Identification of actinobacterium
Strain NH28 was identified based on sequence of 16S 
rRNA gene. The DNA extraction, PCR-mediated amplifi-
cation and sequencing were carried out as described pre-
viously [16]. The closest phylogenetic neighbors based on 
16S rRNA gene similarities were found using the EzTaxon 
server [17].
Biosynthesis of silver nanoparticles from NH28 strain
Actinobacterial strain was inoculated in flask with ISP2 
broth and incubated in rotatory shaker (150 rpm) at 27 °C 
for 14 days. After incubation, the biomass was separated 
by centrifugation at 6000×g, washed three times with 
sterile distilled water, resuspended in sterile distilled 
water and incubated for 48 h at room temperature. The 
biomass was then harvested by centrifugation at 6000×g 
for 15 min. The supernatant was collected and filtrated 
through sterile 0.22-µm filter and treated with 1 mM silver 
nitrate (AgNO3) solution 1:1 (v/v). The reaction mixture 
was kept in rotatory shaker (130 rpm) at 27 °C in dark-
ness up for 72 h. During the incubation period, flasks were 
observed for color change of solution from yellow to dark 
brown.
UV–visible spectroscopy
Biosynthesis of AgNPs was confirmed by recording of 
absorption spectra within the range of 200–700 nm using 
NanoDrop 2000 spectrophotometer (Thermo Scientific, 
USA).
Fourier transform infrared (FTIR) spectroscopy
The FTIR characterization of functional groups of silver 
nanoparticle surface was examined using Spectrum 2000 
spectrophotometer (PerkinElmer). The sample was pre-
pared by dispersing the nanoparticles in a matrix of dry 
potassium bromide (KBr) compressed to form a disk. The 
spectra were measured in the range of 4000–500 cm−1 at a 
resolution of 4 cm−1.
Transmission electron microscopy (TEM) study
TEM analysis of silver nanoparticles was carried out using 
the FEI Tecnai F20 X-Twin TEM microscope, at 100 kV. 
The sample containing dried nanoparticles was diluted with 
sterile, double distilled water, applied on carbon-coated 
cooper TEM grids (400 µm mesh size) and then dried in 
room temperature prior to measurements. The obtained 
data were evaluated by Statistica Software (StatSoft, USA).
Nanoparticle tracking analysis (NTA)
The size and size distribution of synthesized nanoparti-
cles were measured using Nanoparticle Tracking Analysis 
(NanoSight Ltd., Amesbury, UK). Samples were diluted 
with 5 µL of nuclease-free water, injected into the chamber 
and measured.
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Zeta potential analysis
The zeta potential was measured using the Zetasizer ZS 90 
(Malvern Instrument Ltd, UK). For this purpose, 25 µL of 
nanoparticle sample was diluted 10 times with water and 
sonicated for 15 min at 20 Hz to avoid the aggregation of 
nanoparticles. The sample was then filtered with 0.22-µm 
filter and used for zeta potential measurement. Measure-
ments were taken in the range of −200 to +200 mV.
Minimal inhibitory concentration (MIC) of silver 
nanoparticles from NH28 isolate against bacterial 
strains
The MIC was determined against bacterial strains such as 
Salmonella infantis (obtained from Sanitary-Epidemiolog-
ical Station in Torun, Poland), Proteus mirabilis (obtained 
from the collection of microorganisms of the Collegium 
Medicum in Bydgoszcz, Poland), Bacillus subtilis (ATTC 
6633), Staphylococcus aureus (ATTC 6338), Klebsiella 
pneumoniae (ATTC 700603), Pseudomonas aeruginosa 
(ATTC 10145) and Escherichia coli (ATTC 8739). The 
MICs of synthesized AgNPs were determined by broth 
dilution method in the 96 microtiter plates (in triplicate). 
Tryptic Soy Broth (TSB, Becton–Dickinson) was used as 
diluent for bacterial strains. The final concentration of bac-
terial cells in each well was 1 × 106 CFU/mL, and concen-
trations of AgNPs were in the range of 1.25–200 µg/mL. 
The positive and negative controls were also maintained. 
After incubation for 24 h at 37 °C, the microtiter plates 
were read at 450 nm using BIOLOG multimode reader to 
determine the minimum inhibitory concentration values.
In vitro biocompatibility
Cell cultures
The L929 mouse fibroblasts (LGC Standards, Middlesex, 
UK) were used for in vitro cytotoxicity testing. The cells 
were maintained in 25-cm2 tissue culture flasks in RPMI 
1640 medium (Sigma-Aldrich, St. Louis, MO, USA) sup-
plemented with 10 % fetal bovine serum (FBS) (Cytogen, 
Lodz, Poland) and antibiotics: 100 U/mL penicillin and 
100 µg/mL streptomycin (Sigma-Aldrich, St. Louis, MO, 
USA) under standard conditions (37 °C, 5 % CO2). To 
obtain a cell suspension for cytotoxicity assay or to start 
a new culture, confluent monolayers were treated with 
0.25 % trypsin solution (Sigma-Aldrich, St. Louis, MO, 
USA) and their density was evaluated.
THP1-XBlue™ cells derived from the human monocyte 
THP-1 cell line were used for immunostimulatory assay 
and maintained in RPMI 1640 medium supplemented with 
10 % heat-inactivated FBS (Cytogen, Poland), penicillin: 
50 µg/mL, normocin: 100 µg/mL and zeocin: 200 µg/mL 
(Invitrogen, San Diego, CA) at 37 °C in incubator with 5 % 
CO2 and 95 % air. Cells were re-cultured every 3 days to 
maintain concentration of <2 × 106 cells/mL and used with 
<20 passages after thawing.
Both cell culture types were supplemented with fresh 
medium two or three times per week to maintain their 
growth in log phase. Prior to experiments, the viability of 
the cells was assessed by exclusion of trypan blue stain and 
remained in the range of 93–95 %.
Cytotoxicity assay
To evaluate the cytotoxicity of AgNPs, the L929 cells at the 
density of 2 × 105/mL (100 µL per well) were distributed 
into the 96-well plates, and then, nanoparticles at final con-
centration of 1, 5, 10, 25, 50 or 100 µg/mL were added (all 
in triplicate). Untreated cells constituted a positive control 
of viability, whereas cells treated with 2 % saponin (Sigma-
Aldrich, St. Louis, MO, USA) were used as a positive con-
trol of cell lysis. Biogenic AgNPs in culture medium with 
no cells were included as a internal control of a potential 
background. Plates were incubated under standard condi-
tions for 24 h. The cell viability was evaluated by the MTT 
(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide) colorimetric technique based on the ability of 
viable cells to reduce MTT (Cell Proliferation and Cyto-
toxicity Assay, R&D Systems, Minneapolis, MN, USA) 
to formazan crystals. Briefly, following the 24-h incuba-
tion, 10 µL of MTT solution was added to each well. After 
four hour incubation (37 °C, 5 % CO2), the plate was cen-
trifuged (400 g/10 min.), supernatants were removed and 
the intracellularly stored formazan was solubilized with 
200 µL of the dissolving solution for 8 h at room tempera-
ture. The optical density was then measured at a reference 
wavelength of 570 nm using plate reading spectrophotom-
eter Victor 2 (Wallac, Turku, Finland). The half-maximal 
inhibitory concentration (IC50) values were calculated 
using statistic software GraphPad Prism 5 (USA).
Membrane integrity assay
The integrity of cellular membrane of L929 mouse fibro-
blasts was evaluated using standard trypan blue exclusion 
assay. The cells were incubated in the 96-well culture plate 
(1 × 105/well) in the presence of silver nanoparticles in 
various concentrations (1, 5, 10, 25, 50 and 100 µg/mL) in 
triplicate for 24 h. Untreated cells were used as negative 
control (100 % viability), whereas cells treated with 2 % 
saponin constituted a positive control of membrane disin-
tegration. Following the incubation, the medium was dis-
carded and cells were incubated for 2 min with 4 % trypan 
blue in culture medium. Assuming that the dye stains only 
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the cells with damaged cell membrane, the percentage of 
disrupted (dead) and unchanged (viable) cells was esti-
mated using light inverted microscope. The assay was per-
formed in triplicate for each sample and with four technical 
repeats.
Cellular adherence and morphology
The ability of the cells to adherence and to create a tight 
confluent monolayer was evaluated by the incubation of 
previously settled L929 fibroblasts with silver nanoparti-
cles in various concentrations. The cells were introduced 
to a 24-well culture plate (5 × 105/well/mL) and incubated 
overnight to create a tight monolayer exhibiting complete 
confluence. Then, AgNPs in various concentrations (1, 5, 
10, 25, 50 and 100 µg/mL) were added to cellular monolay-
ers in triplicate and incubated for 24 h in humidified condi-
tions in the presence of 5 % CO2. Following the incuba-
tion, monolayers were washed twice to remove detached 
cells and suspended in fresh culture medium. Untreated 
cells were considered negative control (100 % confluence), 
whereas cultures treated with 2 % saponin were used as a 
positive control (induced loss of adherence). To visualize 
the effect of nanoparticles on the cellular adherence and 
morphology, the percentage of the cellular confluence was 
determined by Image J 1.49 image processing software 
(National Institute of Health, Maryland, USA), and the 
photographs of representative cultures were taken under the 
inverted light microscope.
Quantification of NF‑κB induction
The immunostimulatory effect of the silver nanoparticles 
in eukaryotic cells was tested using the THP1-XBlue™ 
cells (Invitrogen, San Diego, CA), which stably express 
an NF-κB/AP-1-inducible reporter system to facilitate the 
monitoring of TLR-induced NF-κB/AP-1 activation, result-
ing in the secretion of embryonic alkaline phosphatase 
(SEAP). To estimate immunostimulatory effect of AgNPs 
in various concentrations, the THP1-XBlue™ indica-
tor cells were plated at an initial density of 1 × 106 cells/
mL in 96-well tissue culture plates (100 µL/well). To each 
well, AgNPs in various concentrations (1, 5, 10, 25, 50 
and 100 µg/mL) were added and incubated for 24 h under 
humidified conditions with 5 % CO2. The untreated cultures 
were used as negative controls, whereas cultures treated 
with lipopolysaccharide (LPS) of Escherichia coli (Sigma-
Aldrich, St. Louis, MO, USA) at final concentration of 1 µg/
mL were used as positive controls. The 20 µL of supernatant 
from each sample was then transferred to a separate 96-well 
plate containing 200 µL of Quanti-Blue reagent (InvivoGen, 
San Diego, CA). The quantification of SEAP as a marker of 
cell activation was developed after 24-h incubation (37 °C, 
5 % CO2). The OD values were measured in multifunctional 
reader Victor 2 (Wallac, Turku, Finland) at the wavelength 
of 650 nm. Experiments were repeated four times in tripli-
cate for each compound and control.
Statistical analyses
The differences between values were tested using the 
Mann–Whitney’s U test for impaired data preceded by 
the evaluation of normality and homogeneity of variances. 
The results were considered statistically significant when 
P < 0.05. For statistical analysis, the STATISTICA 6.0 PL 
software was used (Stat Soft, Poland).
Results
Identification of actinobacterial strain
Almost complete 16S rRNA gene sequence (1376 nucleo-
tides [nt]) of the strain NH28 was determined. The strain 
NH28 was related to Streptomyces kasugaensis M338-M1T 
and found to share 100 % 16S rRNA gene similarity.
Characterization of silver nanoparticles
The color change of cell filtrate from yellow to dark 
brown after treatment with silver nitrate solution was 
observed, due to excitation of surface plasmon vibrations 
of nanoparticles.
The presence of biosynthesized silver nanoparticles 
was confirmed by UV–Vis spectrophotometer analysis, 
which revealed absorbance peak at wavelength of 421 nm 
(Fig. 1a), and TEM analysis, which showed polydispersed 
and spherical in shape nanoparticles with size range of 4.2–
65 nm (±9.7 nm), mean size of 19.9 nm (±13 nm). The 
EDX analysis revealed strong signal of Ag metal in ana-
lyzed sample (Fig. 1b, c).
FTIR studies of AgNPs revealed seven peaks at 3471, 
3195, 2969, 2357, 1673, 1467 and 1158 cm−1, which can 
refer to possible presence of proteins over the surface of 
biosynthesized AgNPs (Fig. 2a).
The Nano Tracking Analysis recorded average size of 
synthesized silver nanoparticles of 52 nm (±25) at the con-
centration of 0.451 × 108 particles/mL (Fig. 2b).
The stabilization of biosynthesized Ag nanoparticles 
was examined by zeta potential measurement. The zeta 
potential value was found to be −13.8 mV (Fig. 2c).
Antibacterial activity against pathogenic bacteria
The antibacterial activity of silver nanoparticles obtained 
from Streptomyces kasugaensis strain NH28 showed 
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reliable activity against all tested bacterial strains. The 
highest antibacterial activity of biosynthesized AgNPs 
was observed against Staphylococcus aureus, followed by 
Klebsiella pneumoniae, Proteus mirabilis and Escherichia 
coli, then Bacillus subtilis, Salmonella infantis and at least 
against Pseudomonas aeruginosa (Table 1).
The lowest MIC value (1.25 µg/mL) of biosynthesized 
AgNPs was found against Staphylococcus aureus, Kleb‑
siella pneumoniae, Proteus mirabilis and Escherichia coli 
(Table 1), which inhibited growth of 48, 29, 23 and 14 % 
bacterial cells, respectively. The MIC of AgNPs against 
Bacillus subtilis was found in concentration of 2.5 µg/mL, 
whereas against Pseudomonas aeruginosa and Salmonella 
infantis of 10 µg/mL (Table 1), which inhibited growth of 
8 % bacterial cells.
In vitro biocompatibility of biogenic silver 
nanoparticles
The safety of biogenic silver nanoparticles on in vitro 
model was evaluated by the incubation of AgNPs in various 
concentrations with L929 fibroblasts and further analysis of 
their viability (MTT reduction assay), cellular monolayer 
confluence (light microscope) and membrane integrity 
(trypan blue exclusion assay).
The viability of untreated L929 fibroblasts remained 
unchanged and constituted 100 %, whereas the cultures 
treated with 2 % saponin exhibited significantly lower 
percentage of viable cells (12.6 ± 3.2; P = 0.004). Simi-
larly, biogenic AgNPs in concentrations of 100 and 50 µg/
mL induced significant reduction in cell viability, in com-
parison with untreated cultures (31.2 ± 6.5 %; P = 0.01) 
Fig. 1  UV–Vis spectrum (a), EDX analysis (b) and TEM micrograph 
(c) of silver nanoparticles
Fig. 2  FTIR spectrum (a) NTA 
(b) and zeta potential distribu-
tion (c) of silver nanoparticles
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and (55.7 ± 6.1 %; P = 0.03) (Fig. 3a). A relatively lower 
viability was observed in cultures treated with AgNPs in a 
concentration of 25 µg/mL (82.9 ± 7.5 %), whereas there 
was no cytotoxic effect observed for concentrations of 1, 
5 and 10 µg/mL. The IC50 value calculated in GraphPad 
Prism software was 64.5 µg/mL (Fig. 3b).
The results of cytotoxicity were consistent with the 
observations from trypan blue exclusion assay as well as 
monolayer confluence experiments. Cellular confluence is 
expressed as a percentage (%±SD) of cells able to adhere 
to the surface of a tissue culture plate measured by Image 
J software and shown on representative photographs from 
light microscope (40×). The membrane integrity was eval-
uated by basic trypan blue exclusion assay. The percent-
ages of cells that did not absorb the dye (viable cells with 
untouched membrane structure) are shown (Fig. 4). The 
experiments were conducted in triplicate and four technical 
repeats.
Untreated cultures exhibited a confluent (100 %) 
tight monolayer, whereas the cultures treated with lysis 
agent displayed a significant loss of monolayer integrity 
(14 ± 5.9 %; P = 0.004). Similarly, the AgNPs used in 
concentrations of 50 and 100 µg/mL interfered with cell 
capacity to adhere, which was observed as a significant 
decrease in monolayer confluence: 68 ± 7.2 (P = 0.04) and 
31 ± 4.7 % (P = 0.002), respectively. There was no sig-
nificant negative effect of AgNPs on cellular integrity when 
used in concentrations of 5 and 10 µg/mL; however, still 
a reduction in monolayer integrity to 90.0 ± 11.3 % and 
84 ± 5.9 %, respectively, was observed. The concentration 
of 1 µg/mL did not affect the monolayer confluence, which 
was similar to conditions of cells cultured in complete 
medium (untreated cells).
The membrane integrity of cells was significantly 
reduced when concentrations 10, 25, 50 and 100 µg/mL 
were used (P < 0.05), (Fig. 4). In contrast, the cellular 
membrane remained unchanged, when AgNPs were intro-
duced in concentrations of 1 and 5 µg/mL.
Immunocompatibility assay using THP1-XBlue cells 
showed that concentrations of biosynthesized AgNPs at 
10 µg/mL generated activation of human monocyte-mac-
rophage cell line. It was also observed that the response of 
monocytes to AgNPs was dose dependent (Fig. 5). Well-
established bacterial stimuli—E. coli lipopolysaccharide—
induced strong activation of monocytes, in comparison with 
untreated cultures (P = 0.004). None of the biosynthesized 
AgNPs induced such high reaction; however, nanoparticles 
used in concentrations of 100 µg/mL (P = 0.01) and 50 µg/
mL (P = 0.03) significantly upregulated the induction of 
NF-κB transcription factor responsible for monocyte acti-
vation (Fig. 5). There was no such effect in case of THP1-
XBlue cells treated with AgNPs in concentration of 1 and 
5 µg/mL, and the obtained values remained on the level of 
untreated cultures.
Discussion
In our study, we confirmed synthesis of silver nanoparticles 
from Streptomyces kasugaensis strain NH28—visually by 
Table 1  Minimum inhibitory concentration of AgNPs from NH28 
strain against different bacterial pathogens
Values expressed in mean ± SD
Tested microorganism MIC
Staphylococcus aureus (ATTC 6338) 1.25 ± 0.078
Klebsiella pneumoniae (ATTC 700603) 1.25 ± 0.007
Proteus mirabilis 1.25 ± 0.035
Escherichia coli (ATTC 8739) 1.25 ± 0.010
Bacillus subtilis (ATTC 6633) 2.5 ± 0.025
Salmonella infantis 10 ± 0.011
Pseudomonas aeruginosa (ATTC 10145) 10 ± 0.025
Fig. 3  Viability of L929 mouse fibroblasts after treatment (24 h, 
37 °C, 5 % CO2) with various concentrations of biogenic silver 
nanoparticles (AgNPs) in comparison with untreated cells (negative 
control) and cells treated with lytic agent (2 % saponin) evaluated 
in MTT reduction assay (a). The IC50 value calculated in GraphPad 
Prism software on the basis of MTT reduction assay (b)
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the color change of reaction mixture and spectroscopically 
(UV–Vis spectroscopy) which revealed peak at charac-
teristic wavelength of 421 nm specific for silver nanopar-
ticles. Similar results were reported by Manivasagan [18] 
or Chauhan [19] who used actinobacteria for synthesis of 
AgNPs and found related values at approximately 420 nm.
Silver nanoparticles exhibit an intense absorption peak 
in the visible region 400–440 nm due to the surface plas-
mon excitation (SPR); this absorption band is observed by 
combined oscillation of free conduction electrons of metal 
nanoparticles in resonance with light wave [20].
The size, shape and stability of the biosynthesized 
AgNPs were characterized by TEM, NTA, FTIR and zeta 
potential analyses. TEM analysis showed small-sized, poly-
dispersed silver nanoparticles. Comparable results of TEM 
analysis were recorded by Subashini [21] who observed 
20–70 nm and spherical silver nanoparticles biosynthesized 
by Streptomyces sp. VITBT7. However, either smaller or 
bigger silver nanoparticles have been derived from actino-
bacteria [22, 23].
Our EDX spectroscopy spectra showed strong signal of 
Ag with high weight percentage of Ag in tested samples, 
which confirmed the presence of silver in the sample.
NTA technique tracks particles for number of steps and 
calculates their size based on the distance travelled. This 
system offers ability to measure concentration and can be 
used to give date about size and size distribution [24]. Sim-
ilar results were recorded by Anasane [25] who observed 
an average size of AgNPs synthesized from two actino-
bacterial strains of 30 and 28 nm and its concentration of 
6.08 × 106 and 6.16 × 108 particles per mL, respectively.
The FTIR analysis of AgNPs is performed to identify 
the possible biomolecules responsible for the reduction of 
Ag ions to AgNPs and to assess stabilized proteins over 
the surface of nanoparticles as a capping agent [26]. The 
absorption band at 3471 cm−1 can be assigned to O–H 
stretching vibration, whereas at 3195 and 2969 cm−1 to 
primary and secondary amines, respectively [27, 28]. 
Peak at 2357 cm−1 can be assigned to N–H stretching 
vibration, at 1673 cm−1 to C=C stretching vibration, and 
1467 cm−1 can be attached to C=C stretching vibrations 
of an aromatic amine group or C–N stretching vibrations 
of aromatic amines (Fig. 3) [29]. The presence of band at 
1158 cm−1 corresponds to C–O stretching vibration [30]. 
Fig. 4  Impact of AgNPs on the confluence of L929 monolayer and 
membrane integrity measured by trypan blue exclusion assay. The 
membrane integrity was evaluated by basic trypan blue exclusion 
assay. The percentages and standard deviations for cells that did not 
absorb the dye (viable cells) are shown
Fig. 5  Immunocompatibility of tested biogenic AgNPs evaluated 
on THP1-XBlue cells. The mean OD values and standard deviations 
for four technical repeats (in triplicate) are presented in relation to 
untreated cells (negative control) and cells treated with bacterial 
lipopolysaccharide (Escherichia coli) as a positive control. The OD 
values were measured at λ = 650 nm
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The above observations confirmed the presence of proteins 
responsible for the reduction process and formation of cap-
ping agent on the surface of AgNPs. It has been reported 
that proteins can bind to nanoparticles either through their 
free amine groups or through cysteine residues and increase 
stabilization of the AgNPs. It is also claimed that carbonyl 
groups of amino acids and peptides have strong ability to 
bind to silver [31–33].
The zeta potential analysis is used to record stability of 
synthesized nanostructures. The higher the negative or pos-
itive zeta potential, the stronger the prevention of AgNPs 
from its aggregation [34, 35]. Our results showed negative 
charge on the surface of biosynthesized AgNPs and its high 
stability. Similar results were reported by Anasane [25] 
and Golinska [36] who studied silver nanoparticles from 
actinobacteria and noticed its zeta potential in the range of 
−16.6 and −24.1 mV. However, Kaler [34] found less sta-
ble mycogenic nanoparticles with charge of −31 mV.
Antibacterial activity of biogenic silver nanoparti-
cles has been proven by many researchers [3, 36–40]. In 
our study, we recorded high antibacterial activity of silver 
nanoparticles from Streptomyces kasugaensis strain NH28 
against Gram-positive (B. subtilis, S. aureus) and Gram-
negative (S. infantis, P. mirabilis, K. pneumoniae, P. aerug‑
inosa, E. coli) isolates. The MIC values of silver nanoparti-
cles against bacterial strains obtained in this study were low 
and confirmed high antibacterial activity of NPs. The low 
values of MIC after treatment bacteria with AgNPs were 
also found by other authors. Paredes [41] observed the MIC 
values of AgNPs at 0.25 µg/mL for MRSA and 0.50 µg/mL 
for E. coli O157:H7. Similarly, Zarei [42] determinates low 
MIC value of biosynthesized AgNPs for Escherichia coli 
O157:H7 and Salmonella typhimurium, both at 3.12 µg/
mL. In other studies, Ansari [38] estimated the MIC value 
at 12.5 µg/mL for reference strain S. aureus ATCC25923. 
However, Singh [43] who studied MIC of AgNPs synthe-
sized from Acinetobacter calcoaceticus reported activity of 
AgNPs against human pathogenic bacteria in much higher 
concentration range of 150–600 μg/mL as compared to our 
findings.
It is proposed that antibacterial activity of biosynthe-
sized silver nanoparticles is related to interaction of AgNPs 
with sulfur-containing proteins present in cell membrane. 
It causes disturbance of its power function, disintegration 
of membrane structure and release of cell contents [9, 44–
46]. It has been reported that antimicrobial activity of sil-
ver nanoparticles is related to the formation of free oxygen 
radicals, which induce cell membrane damage [47]. The 
cellular proteins, including enzymes and amino acids resi-
dues [48] as well as DNA, may be the potential sites for the 
AgNPs. The possible damage caused by the AgNPs react-
ing with DNA may affect on cell division and DNA rep-
lication and finally leading to the cell death [49, 50]. The 
silver nanoparticles getting into the bacterial cells can also 
release silver ions, which may contribute to the antimicro-
bial activity of metal nanoparticles [18, 19].
It is claimed that the total surface area-to-volume ratios 
of the nanoparticles affect on its antimicrobial properties. 
Thus, smaller nanoparticles display higher antibacterial 
activity when compared to bigger ones [51]. In the present 
study, we found small-sized (mean 19.3 nm) nanoparticles 
from Streptomyces kasugaensis strain NH28.
Silver nanoparticles can be responsible for release of 
lipopolysaccharides and membrane proteins, collapsing of 
bacterial membrane potential induced by drop of ATP level 
by nano-Ag [52, 53]. Researches propose many mecha-
nisms of AgNPs antibacterial activity, but still exact mecha-
nism has not been confirmed and needs further studies.
In our study, we have aimed to evaluate the cytotoxic-
ity of obtained AgNPs in a direct cytotoxicity assay toward 
routinely used in such experiments cell line of L929 fibro-
blasts. We found that silver nanoparticles at concentration 
1 and 5 µg/mL did not show any cytotoxic properties and 
the viability of target cells remained at the same level as 
untreated controls. The cytotoxic effect was observed, 
especially for high concentrations of AgNPs, such as 
50 µg/mL. The IC50 value was established at 64.5 μg/
mL. Arora [54] used AgNPs of 7–20 nm and reported 
that concentrations of 25 and 100 μg/mL did not induce 
morphological changes compared to control cells, and 
the IC50 value was equal to 61 μg/mL—similar to the 
value obtained in our study. It has also been reported that 
smaller-sized AgNPs exhibit high cytotoxic potential than 
larger-sized nanoparticles [55, 56]. Park (2011) charac-
terized 5-nm particles as more toxic and 20- and 50-nm 
particles as less toxic even when compared to silver ions. 
Similarly to our study, research was performed on L929 
fibroblast cells line, routinely used in cytotoxicity assays. 
Barua [57] performed a research on HeLa cells, which 
revealed that particle size in range of 7–14 nm and concen-
trations up to 20 µg/mL did not affect the viability of the 
cells. However, in MTT assay they showed that silver nan-
oparticles inhibited the HeLa cells proliferation, and this 
phenomenon was dose dependent. Results presented here 
shows that biogenic AgNPs obtained by us in a model of 
actinomycetes exhibit low cytotoxicity confirmed in cyto-
toxicity assay and by high IC50 value. What is more, we 
have also showed that the doses below 10 µg/mL are not 
only safe in the context of direct cytotoxicity but also do 
not affect membrane integrity and the ability of the cells to 
adhere. Those properties are very crucial in maintenance 
of cellular barrier function on various levels: epithelial, 
endothelial or intestinal [58]. Studies confirm that AgNPs 
as well as silver ions are responsible for inducing toxicity 
in organisms [59, 60]. Many authors suggested that ROS 
plays central role in silver nanoparticle-induced cell death 
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[61]. Studies have shown that most common mechanisms 
of AgNPs toxicity are a result of oxidative stress [62, 63]. 
Silver nanoparticles generate high intracellular ROS level 
and decline antioxidant enzymes like GSH, which leads to 
disconcert functions of cell [54, 62]. AgNPs disrupt nor-
mal cellular function, affect the membrane integrity and 
induce various apoptotic signaling genes of cells, lead-
ing to programmed cell death [64]. The cytotoxic effects 
of silver nanoparticles can also be generated due to active 
physicochemical interaction of silver atoms with the func-
tional groups of cell proteins [65]. It has been recorded 
that biogenic nanoparticles caused lesser cytotoxicity com-
pared with silver ions or commercial silver nanoparticles 
[46].
The immune cells are very sensitive indicators that rec-
ognize and rapidly react to foreign antigens such as micro-
biological, physical and chemical ones. In vitro immuno-
compatibility assay on THP1-XBlue cells revealed that 
biogenic silver nanoparticles in concentration of 5 µg/mL 
or lower do not cause the activation of monocytes. How-
ever, concentrations of 50 µg/mL or higher significantly 
upregulated the monocyte activation. Similarly to our 
results, Ste˛pkowski [66] reported that NF-κB have been 
activated after exposure to AgNPs (100 µg/mL), and this 
effect of action was observed only in HepG2 (human liver 
carcinoma cell line) cells but not in A549 (non-small cell 
lung cancer line) cells, which can be induced by antioxi-
dants. The activation mode in many immune cells, includ-
ing monocytes, is NF-κB-dependent, and if stimulated, 
the cells secrete inflammatory cytokines, leading to the 
immune response such as inflammation [67]. Many studies 
showed that silver nanoparticles can provide an activation 
signal for NF-κB and induce the production of pro-inflam-
matory mediators such as TNF-α, IL-8, IL-2 and IL-6 [68, 
69]. Shi [70] also noticed that AgNPs could induce the 
injury and dysfunction of human umbilical vein endothe-
lial cells through the activation of NF-kB, which is asso-
ciated with oxidative stress, induced by AgNPs. Here we 
report that biogenic AgNPs obtained in actinomyces model 
exhibit low cytotoxicity and weak stimulatory potential to 
activate monocytes—favorable features that will be further 
investigated. Based on obtained data, we assume that sil-
ver nanoparticles can be a promising and safe antibacterial 
agent.
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